-
Value Communications With US Payers: The Value of Storytelling
Mar 10, 2025, 14:00 PM -
Reliability of Insurance Claims to Categorize Obesity in Patients with Obstructive Sleep Apnea
Mar 10, 2025, 14:00 PM -
Spillover Effects of Medical Innovations: A Generic and Scalable Approach to Measure the Societal Value of Avoided Informal Care Time
Mar 10, 2025, 14:00 PM -
Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023
Mar 10, 2025, 14:00 PM -
Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis
Mar 10, 2025, 14:00 PM -
Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia
Mar 10, 2025, 14:00 PM -
A Case-Study on the Implementation of the Population Health Agreement for Inclisiran in England
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns for Castration-Sensitive Prostate Cancer Between 2012 and 2024: A Systematic Review
Mar 10, 2025, 14:00 PM -
Retrospective Analysis of Cannabis Hyperemesis Syndrome (CHS) Using US Electronic Medical Records: Demographics and Clinical Characteristics
Mar 10, 2025, 14:00 PM -
Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR
Mar 10, 2025, 14:00 PM -
Evaluating the National and Regional Prevalence and Incidence Rates of Hepatitis Delta Virus Among Patients With Hepatitis B Virus Infection in Italy
Mar 10, 2025, 14:00 PM -
Development of a Patient Reported Outcome Measure for GastroIntestinal Recoveryafter Surgery (PRO-diGI)
Mar 10, 2025, 14:00 PM -
Value of Multi-Indication Immunotherapies for the Treatment of Autoimmune Diseases in the United States (US)
Mar 10, 2025, 14:00 PM -
Comparing Hospital Prices Paid by Commercial Insurance Plans at 340B vs. Non-340B Hospitals: Implications for Employers and Patients
Mar 10, 2025, 14:00 PM -
Assessing the Impact of the United States (US) Inflation Reduction Act (IRA) Regulations on Investment Incentives for Orphan Disease Drug Development
Mar 10, 2025, 14:00 PM -
Leveraging a Novel Mixed-Methods Approach to Deepen Insights From Exit Interviews and Trial Data in a Randomized Trial of Cancer Cachexia
Mar 10, 2025, 14:00 PM -
Evaluating Electronic Data Network and Direct Facility Retrieval Data Sources for Improved Patient Record Capture in Observational Studies
Mar 10, 2025, 14:00 PM -
Systematic Literature Review of Recombinant C1 Esterase Inhibitor (rhC1-INH) and Other Products for the On-Demand Treatment of Hereditary Angioedema Attacks
Mar 10, 2025, 14:00 PM -
Assessing the Validity of the SF-36 Health Survey Among Chinese Individuals with Spinal Cord Injuries
Mar 10, 2025, 14:00 PM -
Heredofamilial Amyloidosis Due to Transthyretin (hATTR): Cost Analysis From the Perspective of the Public Health Sector in Mexico
Mar 10, 2025, 14:00 PM
